Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dunn

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
Trials|September 18, 2020
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trialElizabeth C James, David Dunn, Adrian D Cook, et al.
HIV Medicine|October 11, 2021
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adultsJames E Burns, Oliver Stirrup, Laura Waters, et al.
The Journal of Infectious Diseases|February 6, 2008
Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adultsDavid Dunn, Patrick Woodburn, Trinh Duong, et al.
Antiviral Therapy|April 14, 2010
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo dataHuw Price, David Asboe, Anton Pozniak, et al.
Pediatric Neurology|October 10, 2022
Characterizing Sleep Phenotypes in Children With Newly Diagnosed EpilepsyTemitayo Oyegbile-Chidi, Danielle Harvey, David Dunn, et al.
AIDS (London, England)|January 27, 2022
Diagnosis delays in the UK according to pre or postmigration acquisition of HIVOliver Stirrup, Anna Tostevin, Manon Ragonnet-Cronin, et al.
Pediatrics in Review|February 5, 2008
Psychiatric disorders in children and adolescents who have epilepsyJana E Jones, Joan K Austin, Rochelle Caplan, et al.
Epilepsia|June 2, 2023
Impact of sociodemographic disadvantage on neurobehavioral outcomes in children with newly diagnosed seizures and their unaffected siblings over 36 monthsTemitayo Oyegbile-Chidi, Danielle Harvey, Jana Jones, et al.
Journal of the International AIDS Society|November 15, 2014
Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UKKate El Bouzidi, Ellen White, Jean L Mbisa, et al.
Child and Adolescent Psychiatry and Mental Health|September 28, 2007
A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderGabrielle A Carlson, David Dunn, Douglas Kelsey, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Trials|September 18, 2020
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trialElizabeth C James, David Dunn, Adrian D Cook, et al.
HIV Medicine|October 11, 2021
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adultsJames E Burns, Oliver Stirrup, Laura Waters, et al.
The Journal of Infectious Diseases|February 6, 2008
Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adultsDavid Dunn, Patrick Woodburn, Trinh Duong, et al.
Antiviral Therapy|April 14, 2010
Positive and negative drug selection pressures on the N348I connection domain mutation: new insights from in vivo dataHuw Price, David Asboe, Anton Pozniak, et al.
Pediatric Neurology|October 10, 2022
Characterizing Sleep Phenotypes in Children With Newly Diagnosed EpilepsyTemitayo Oyegbile-Chidi, Danielle Harvey, David Dunn, et al.
AIDS (London, England)|January 27, 2022
Diagnosis delays in the UK according to pre or postmigration acquisition of HIVOliver Stirrup, Anna Tostevin, Manon Ragonnet-Cronin, et al.
Pediatrics in Review|February 5, 2008
Psychiatric disorders in children and adolescents who have epilepsyJana E Jones, Joan K Austin, Rochelle Caplan, et al.
Epilepsia|June 2, 2023
Impact of sociodemographic disadvantage on neurobehavioral outcomes in children with newly diagnosed seizures and their unaffected siblings over 36 monthsTemitayo Oyegbile-Chidi, Danielle Harvey, Jana Jones, et al.
Journal of the International AIDS Society|November 15, 2014
Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UKKate El Bouzidi, Ellen White, Jean L Mbisa, et al.
Child and Adolescent Psychiatry and Mental Health|September 28, 2007
A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorderGabrielle A Carlson, David Dunn, Douglas Kelsey, et al.
Pageof 15